Vernolide-A, a sesquiterpene lactone fromVernonia cinerea,induces apoptosis in B16F-10 melanoma cells by modulating p53 and caspase-3 gene expressions and regulating NF-κB-mediated bcl-2 activation
Authors:
- Poyil PratheeshkumarPoyil Pratheeshkumar
- Girija KuttanGKGirija Kuttan
- 7 June 2011
- journal article
- research article
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 34 (3) , 261-270
Abstract
In this study, we investigated the effect of vernolide-A on the induction of apoptosis as well as its regulatory effect on the activation of transcription factors in B16F-10 melanoma cells. Treatment of B16F-10 cells with nontoxic concentrations of vernolide-A showed the presence of apoptotic bodies and induced DNA fragmentation in a dose-dependent manner. Cell-cycle analysis and TUNEL assays also confirmed the observation. The proapoptotic genes, p53, Bax, caspase-9, and caspase-3, were upregulated in vernolide-A–treated cells, whereas the antiapoptotic gene, Bcl-2, was downregulated. vernolide-A treatment also showed a downregulation of cyclin D1 expression and upregulated p21 and p27 gene expression in B16F-10 melanoma cells. The study also reveals that vernolide-A treatment could alter the production and expression of proinflammatory cytokines and could inhibit the activation and nuclear translocation of p65, p50, and c-Rel subunits of nuclear factor-κB and other transcription factors, such as c-fos, activated transcription factor-2, and cyclic adenosine monophosphate response-element–binding protein in B16F-10 melanoma cells. These results suggest that vernolide-A induces apoptosis via activation of p53-induced, caspase-3-mediated proapoptotic signaling and suppression of NF-κB–induced, bcl-2-mediated survival signaling.Keywords
This publication has 37 references indexed in Scilit:
- A cytokine-mediated link between innate immunity, inflammation, and cancerJournal of Clinical Investigation, 2007
- The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic inventionMolecular Cancer, 2007
- Inhibitor κB and Nuclear Factor κB in Granulocyte‐Macrophage Colony‐Stimulating Factor Antagonism of Dexamethasone Suppression of the Macrophage Response toAspergillus fumigatusConidiaThe Journal of Infectious Diseases, 2006
- NF-κB inhibition: A double-edged sword in cancer?European Journal of Cancer, 2006
- Cyclin D1: polymorphism, aberrant splicing and cancer riskOncogene, 2006
- Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition CohortCancer Epidemiology, Biomarkers & Prevention, 2005
- Echinocystic acid induces apoptosis in HL-60 cells through mitochondria-mediated death pathwayCancer Letters, 2004
- Diepoxybutane induces caspase and p53-mediated apoptosis in human lymphoblastsToxicology and Applied Pharmacology, 2004
- Sesquiterpene Lactones Specifically Inhibit Activation of NF-κB by Preventing the Degradation of IκB-α and IκB-βJournal of Biological Chemistry, 1998
- Bcl-2 Overexpression and Smoking History in Head and Neck CancerJNCI: Journal of the National Cancer Institute, 1995